Back to GetFilings.com



Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

     
(Mark One)
 
[X]   Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: August 31, 2002
    or
[   ]   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from _______________________ to _______________________

Commission File Number 1-1520

 
GenCorp Inc.
(Exact name of registrant as specified in its charter)
     
Ohio   34-0244000
(State of Incorporation)   (I.R.S. Employer Identification No.)
 
Highway 50 and Aerojet Road    
Rancho Cordova, California   95670
(Address of Principal Executive Offices)   (Zip Code)
 
P.O. Box 537012    
Sacramento, California   95853-7012
(Mailing Address)   (Zip Code)

Registrant’s telephone number, including area code (916) 355-4000

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months, (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [  ]

     As of September 30, 2002, there were 43,234,894 outstanding shares of the Company’s Common Stock, $0.10 par value.



 


TABLE OF CONTENTS

Part I – FINANCIAL INFORMATION
Item 1. Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
Signatures
CERTIFICATIONS
Restricted Stock Agreement
Asset Purchase Agreement
Agreement to Amend and Restate


Table of Contents

GenCorp Inc.

Quarterly Report on Form 10-Q
For the Quarterly Period Ended August 31, 2002

Table of Contents

         
Item
Number
      Page
 
    PART I – FINANCIAL INFORMATION    
1   Financial Statements   1
         
2   Management’s Discussion and Analysis of Financial Condition and Results of Operations   27
         
3   Quantitative and Qualitative Disclosures About Market Risk   37
         
4   Controls and Procedures   38
         
    PART II – OTHER INFORMATION    
         
1   Legal Proceedings   38
         
5   Other Information   38
         
6   Exhibits and Reports on Form 8-K   38
         
    SIGNATURES    
         
    Signatures   40
         
    CERTIFICATIONS    
         
    Certifications   41

 


Table of Contents

Part I – FINANCIAL INFORMATION

Item 1. Financial Statements

GenCorp Inc.

Condensed Consolidated Statements of Income
(Unaudited)

                                 
    Three months ended   Nine months ended
    August 31,   August 31,
   
 
    2002   2001   2002   2001
   
 
 
 
            (Restated)           (Restated)
                     
    (In millions, except per share amounts)
Net Sales
  $ 266     $ 356     $ 818     $ 1,119  
Costs and Expenses
                               
Cost of products sold
    223       313       683       979  
Selling, general and administrative
    8       12       33       32  
Depreciation and amortization
    18       21       48       58  
Interest expense
    4       10       11       28  
Other (income) expense, net
    1       (5 )     7       (9 )
Foreign exchange gain
                      (11 )
Restructuring charge
                      19  
Unusual items, net
                9       8  
 
   
     
     
     
 
Income Before Income Taxes
    12       5       27       15  
Provision (credit) for income taxes
    4       2       10       (7 )
 
   
     
     
     
 
Net Income
  $ 8     $ 3     $ 17     $ 22  
 
   
     
     
     
 
Earnings Per Share of Common Stock
                               
Basic
  $ 0.19     $ 0.07     $ 0.40     $ 0.52  
 
   
     
     
     
 
Diluted
  $ 0.19     $ 0.07     $ 0.40     $ 0.51  
 
   
     
     
     
 
Weighted average shares of common stock outstanding
    42.9       42.3       42.8       42.1  
 
   
     
     
     
 
Weighted average shares of common stock outstanding, assuming dilution
    51.4       42.8       43.2       42.5  
 
   
     
     
     
 
Dividends Declared Per Share of Common Stock
  $ 0.03     $ 0.03     $ 0.09     $ 0.09  
 
   
     
     
     
 

See Notes to Unaudited Condensed Consolidated Financial Statements.

-1-


Table of Contents

GenCorp Inc.

Condensed Consolidated Balance Sheets

                   
      August 31   November 30,
      2002   2001
     
 
      (unaudited)
      (Dollars in millions,
      except per share amounts)
     
Current Assets
               
Cash and cash equivalents
  $ 37     $ 44  
Accounts receivable
    128       173  
Inventories, net
    184       167  
Recoverable from the U.S. Government and other third parties for environmental remediation
    18       18  
Current deferred income taxes
    7       14  
Prepaid expenses and other
    5       4  
 
   
     
 
 
Total Current Assets
    379       420  
Noncurrent Assets
               
Property, plant and equipment, net
    453       454  
Recoverable from the U.S. Government and other third parties for environmental remediation
    217       140  
Deferred income taxes
          6  
Prepaid pension asset
    326       287  
Goodwill, net
    83       65  
Other noncurrent assets, net
    74       96  
 
   
     
 
 
Total Assets
  $ 1,532     $ 1,468  
 
   
     
 
Current Liabilities
               
Short-term borrowings and current portion of long-term debt
  $ 20     $ 17  
Accounts payable
    79       87  
Reserves for environmental remediation
    30       35  
Income taxes payable
    6       29  
Other current liabilities
    242       301  
 
   
     
 
 
Total Current Liabilities
    377       469  
Noncurrent Liabilities
               
Convertible subordinated notes
    150        
Other long-term debt, net of current portion
    122       197  
Reserves for environmental remediation
    316       244  
Postretirement benefits other than pensions
    177       194  
Deferred income taxes
    11        
Other noncurrent liabilities
    33       54  
 
   
     
 
 
Total Liabilities
    1,186       1,158  
Commitments and Contingent Liabilities
Shareholders’ Equity
               
Preference stock, par value of $1.00 per share; 15 million shares authorized; none issued or outstanding
           
Common stock, par value of $0.10 per share; 150 million shares authorized; 43.5 million shares issued, 43.0 million outstanding as of August 31, 2002 (43.3 million shares issued, 42.6 million shares outstanding as of November 30, 2001)
    4       4  
Other capital
    13       9  
Retained earnings
    344       331  
Accumulated other comprehensive loss, net of income taxes
    (15 )     (34 )
 
   
     
 
 
Total Shareholders’ Equity
    346       310  
 
   
     
 
 
Total Liabilities and Shareholders’ Equity
  $ 1,532     $ 1,468  
 
   
     
 

See Notes to Unaudited Condensed Consolidated Financial Statements.

-2-


Table of Contents

GenCorp Inc.

Condensed Consolidated Statements of Cash Flows
(Unaudited)

                       
          Nine months ended
          August 31
         
          2002   2001
         
 
                  (Restated)
          (Dollars in millions)
         
Operating Activities
               
Net income
  $ 17     $ 22  
Adjustments to reconcile net income to net cash used in operating activities:
               
 
Net loss related to reacquisition of minority ownership interest in subsidiary
    2        
 
Foreign exchange gain
          (11 )
 
Depreciation, amortization and gain on asset disposition
    48       55  
 
Deferred income taxes
    15       33  
 
Changes in assets and liabilities, net of effects of acquisitions of businesses:
               
   
Current assets
    36       (3 )
   
Noncurrent assets
    (110 )     (45 )
   
Current liabilities
    (101 )     (62 )
   
Noncurrent liabilities
    53       (33 )
 
   
     
 
     
Net Cash Used in Operating Activities
    (40 )     (44 )
Investing Activities
               
Capital expenditures
    (31 )     (29 )
Proceeds from sale of fixed assets
    4       5  
Acquisition of businesses, net of cash acquired
    (8 )     (179 )
 
   
     
 
     
Net Cash Used in Investing Activities
    (35 )     (203 )
Financing Activities
               
Proceeds from issuance of convertible debt, net of issuance costs
    144        
Repayments on revolving credit facility, net
    (60 )     (104 )
Net short-term debt (repayments) incurred
    (6 )     20  
Proceeds from the issuance of long-term debt
    25       350  
Repayments of long-term debt
    (37 )      
Dividends paid
    (4 )     (4 )
Other equity transactions
    4       4  
 
   
     
 
     
Net Cash Provided by Financing Activities
    66       266  
 
   
     
 
Effect of exchange rate fluctuations on cash and cash equivalents
    2        
 
   
     
 
Net (Decrease) Increase in Cash and Cash Equivalents
    (7 )     19  
Cash and Cash Equivalents at Beginning of Period
    44       17  
 
   
     
 
Cash and Cash Equivalents at End of Period
  $ 37     $ 36  
 
   
     
 

See Notes to Unaudited Condensed Consolidated Financial Statements.

-3-


Table of Contents

GenCorp Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

1. Basis of Presentation and Nature of Operations

     The accompanying unaudited Condensed Consolidated Financial Statements of GenCorp Inc. (GenCorp or the Company) include the accounts of the parent company and its wholly-owned and majority-owned subsidiaries. These interim financial statements have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all of the information and notes required by accounting principles generally accepted in the United States (GAAP). These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in the GenCorp Annual Report on Form 10-K for the fiscal year ended November 30, 2001, as filed with the Securities and Exchange Commission (SEC).

     In the opinion of management, the accompanying Unaudited Condensed Consolidated Financial Statements reflect all adjustments, consisting only of normal recurring accruals, necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the periods presented. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of financial statements in conformity with GAAP requires management to make certain assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. In addition, our operating results for interim periods may not be indicative of the results of operations for a full fiscal year.

     Certain reclassifications have been made to financial information for prior periods to conform to the current period’s presentation.

     Headquartered in Sacramento, California, GenCorp is a multinational manufacturing company operating primarily in North America and Europe. The Company’s operations are organized into three segments: GDX Automotive, Aerospace and Defense and Fine Chemicals. The Company’s GDX Automotive segment is a major automotive supplier, engaged in the development, manufacture and sale of highly engineered extruded and molded rubber and plastic sealing systems for vehicle bodies and windows for automotive original equipment manufacturers. The Aerospace and Defense segment includes the operations of Aerojet-General Corporation (Aerojet). Aerojet’s business primarily serves high technology markets that include Space and Strategic Rocket Propulsion and Tactical Weapons. Primary customers served include major prime contractors to the U.S. Government, the Department of Defense and the National Aeronautics and Space Administration (NASA). In addition, Aerojet has significant undeveloped real estate holdings in Sacramento, California. The Company’s real estate business is a component of its Aerospace and Defense segment. The Company’s Fine Chemicals segment consists of the operations of Aerojet Fine Chemicals LLC (AFC). AFC supplies special intermediates and active pharmaceutical ingredients primarily to commercial customers in the pharmaceutical industry. See Note 11 for financial information for the Company’s operating segments.

     See Note 3 for information related to the acquisition and disposition of businesses for the periods covered by this report.

-4-


Table of Contents

2. Restatement of Previously Issued Financial Statements

     In January 2002, the Company became aware of certain potential accounting issues at two of its GDX Automotive manufacturing plants in North America. The Company promptly notified both its Audit Committee and its independent accountants. Under the direction and oversight of the Audit Committee and with the assistance of outside legal advisors and accounting consultants, the Company conducted an inquiry into these and related accounting issues as well as a more complete evaluation of accounting practices and internal control processes throughout the Company. As a result of this process, due primarily to activities at one GDX Automotive manufacturing plant, the Company restated its previously issued financial statements for the years ended November 30, 2000 and November 30, 1999. Unaudited quarterly financial information for the first three quarters of the year ended November 30, 2001 was also restated.

     The revisions primarily arose from the correction of certain balance sheet and income statement items, which among other things, related to the accounting for customer-owned tooling and recognition of liabilities at one of the Company’s GDX Automotive manufacturing plants that the Company has determined were not properly recorded in the Company’s accounting records.

     Unless otherwise expressly stated, all financial information in this Quarterly Report on Form 10-Q is presented inclusive of these revisions.

Condensed Consolidated Statements of Income

                                                   
                      2001                
                     
               
      First Quarter   Second Quarter   Third Quarter
     
 
 
      Previously           Previously           Previously        
      Reported*   Restated   Reported*   Restated   Reported*   Restated
     
 
 
 
 
 
              (Dollars in millions, except per share amounts)        
Net Sales
  $ 353     $ 353     $ 410     $ 410     $ 356     $ 356  
Costs and Expenses
                                               
Cost of products sold
    309       314       354       352       309       313  
Selling, general and administrative
    11       11       10       9       13       12  
Depreciation and amortization
    18       17       20       20       21       21  
Interest expense
    9       9       9       9       10       10  
Other income, net
    (1 )     (1 )     (3 )     (3 )     (5 )     (5 )
Foreign exchange gain
    (11 )     (11 )                        
Restructuring charge
                19       19        </